$1.39 Million is the total value of Opti Capital Management, LP's 56 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 89.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | FIVE9 INCnote 0.500% 6/0 | $61,714 | -99.9% | 65,606,000 | +7.4% | 4.44% | -11.1% | |
Buy | NOVOCURE LTDnote 11/0 | $61,522 | -99.6% | 71,346,000 | +296.4% | 4.43% | +236.4% | |
New | ROYAL CARIBBEAN GROUPnote 6.000% 8/1 | $59,292 | – | 30,000,000 | +100.0% | 4.27% | – | |
New | SAREPTA THERAPEUTICS INCnote 1.250% 9/1 | $55,107 | – | 49,000,000 | +100.0% | 3.96% | – | |
Buy | BLACKLINE INCnote 3/1 | $53,903 | -99.9% | 62,500,000 | +6.8% | 3.88% | -7.9% | |
Buy | HUBSPOT INCnote 0.375% 6/0 | $50,018 | -99.9% | 28,053,000 | +9.4% | 3.60% | -13.3% | |
New | WESTERN DIGITAL CORP.note 1.500% 2/0 | $48,577 | – | 49,354,000 | +100.0% | 3.50% | – | |
Buy | LYFT INCnote 1.500% 5/1 | $39,678 | -99.8% | 43,000,000 | +72.0% | 2.86% | +49.6% | |
New | BOOKING HOLDINGS INCnote 0.750% 5/0 | $34,329 | – | 20,500,000 | +100.0% | 2.47% | – | |
Buy | 3D SYS CORP DELnote 11/1 | $32,416 | -99.9% | 44,000,000 | +46.7% | 2.33% | +20.8% | |
Buy | OMNICELL COMnote 0.250% 9/1 | $29,458 | -99.9% | 32,500,000 | +30.0% | 2.12% | -1.3% | |
Buy | SPOTIFY USA INCnote 3/1 | $28,985 | -99.8% | 34,000,000 | +94.3% | 2.09% | +65.6% | |
Buy | OPKO HEALTH INCnote 4.500% 2/1 | $28,808 | -99.9% | 29,173,000 | +44.2% | 2.07% | +19.3% | |
Buy | FASTLY INCnote 3/1 | $28,411 | -99.9% | 33,181,000 | +31.8% | 2.04% | +15.3% | |
Buy | VAREX IMAGING CORPnote 4.000% 6/0 | $25,892 | -99.9% | 22,800,000 | +51.5% | 1.86% | +14.4% | |
Buy | PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $24,997 | -99.8% | 27,446,000 | +71.0% | 1.80% | +42.7% | |
New | GUIDEWIRE SOFTWARE INCnote 1.250% 3/1 | $24,727 | – | 24,150,000 | +100.0% | 1.78% | – | |
New | ON SEMICONDUCTOR CORPnote 5/0 | $21,570 | – | 11,954,000 | +100.0% | 1.55% | – | |
Buy | BLOCK INCnote 5/0 | $21,155 | -99.7% | 25,177,000 | +151.8% | 1.52% | +116.2% | |
Buy | VERINT SYSTEMS INCnote 0.250% 4/1 | $20,214 | -99.9% | 23,469,000 | +4.3% | 1.46% | -13.5% | |
Buy | BANDWIDTH INCnote 0.250% 3/0 | $19,959 | -99.8% | 24,679,000 | +70.2% | 1.44% | +49.0% | |
Buy | HEALTH CATALYST INCnote 2.500% 4/1 | $19,852 | -99.9% | 20,759,000 | +14.3% | 1.43% | -2.8% | |
New | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $19,757 | – | 20,500,000 | +100.0% | 1.42% | – | |
New | WINNEBAGO INDS INCnote 1.500% 4/0 | $19,579 | – | 17,413,000 | +100.0% | 1.41% | – | |
Buy | NEVRO CORPnote 2.750% 4/0 | $18,574 | -99.9% | 19,500,000 | +11.4% | 1.34% | -4.4% | |
Buy | 8X8 INC NEWnote 0.500% 2/0 | $15,266 | -99.9% | 15,820,000 | +6.6% | 1.10% | -8.1% | |
New | EQT CORPnote 1.750% 5/0 | $13,917 | – | 5,000,000 | +100.0% | 1.00% | – | |
Buy | CUTERA INCnote 2.250% 3/1 | $13,179 | -99.8% | 17,000,000 | +166.9% | 0.95% | +101.7% | |
New | PARSONS CORP DELnote 0.250% 8/1 | $10,601 | – | 8,321,000 | +100.0% | 0.76% | – | |
New | RAPID7 INCnote 0.250% 3/1 | $9,878 | – | 11,500,000 | +100.0% | 0.71% | – | |
New | Q2 HLDGS INCnote 0.750% 6/0 | $9,154 | – | 10,427,000 | +100.0% | 0.66% | – | |
New | AFFIRM HLDGS INCnote 11/1 | $7,530 | – | 10,000,000 | +100.0% | 0.54% | – | |
New | INFINERA CORPnote 3.750% 8/0 | $3,275 | – | 3,500,000 | +100.0% | 0.24% | – | |
New | ALTERYX INCnote 1.000% 8/0 | $3,130 | – | 3,500,000 | +100.0% | 0.22% | – | |
New | EURONET WORLDWIDE INCnote 0.750% 3/1 | $2,309 | – | 2,500,000 | +100.0% | 0.17% | – | |
New | FARFETCH LTDnote 3.750% 5/0 | $549 | – | 1,000,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
NEW RELIC INC | 14 | Q1 2023 | 7.6% |
8X8 INC NEW | 13 | Q3 2023 | 7.4% |
MANDIANT INC | 12 | Q1 2022 | 9.9% |
NUTANIX INC | 12 | Q4 2022 | 7.3% |
OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
ALTERYX INC | 10 | Q3 2023 | 4.6% |
IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.